Background: The aim of this study was to investigate the predictive value of estimated glomerular filtration rate (eGFR) ), respectively. In receiver operating characteristic curve analysis for prediction of 1-year MACE, the area under the curve based on the CKD-EPI equation was greater than that using the MDRD Study equation (CKD-EPI equation vs. MDRD Study equation: 0.691 vs. 0.674, p=0.041). Multivariate analysis using a Cox proportional hazards model revealed that the eGFR calculated with the CKD-EPI equation was an independent predictor of the occurrence of MACE within 1 year after AMI. However, eGFR calculated with the MDRD Study equation did not have predictive value. Furthermore, the eGFR calculated with the CKD-EPI equation had incremental prognostic value for established risk factors (chi-square=5.78, p=0.016). Conclusion: The eGFR calculated using the CKD-EPI equation was an independent predictor of 1-year MACE in elderly patients with AMI.
Background: The aim of this study was to investigate the predictive value of estimated glomerular filtration rate (eGFR) calculated with the simplified Modification of Diet in Renal Disease (MDRD) Study and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations for prognosis in elderly patients with acute myocardial infarction (AMI). Methods: This study included 1,372 patients (mean age, 64.2±11.8 years; men, 67.9%) entered in the Kyungpook National University Hospital Acute Myocardial Infarction Registry from November 2005 to February 2010. We analyzed 1-year major adverse cardiac events (MACE) according to the eGFR calculated with the simplified MDRD Study and CKD-EPI equations. Results: The mean eGFR values calculated with the MDRD Study and CKD-EPI equations were 81.3±44. 4 and 78.5±27.1 mL/(min/1.73 m 2 ), respectively. In receiver operating characteristic curve analysis for prediction of 1-year MACE, the area under the curve based on the CKD-EPI equation was greater than that using the MDRD Study equation (CKD-EPI equation vs. MDRD Study equation: 0.691 vs. 0.674, p=0.041). Multivariate analysis using a Cox proportional hazards model revealed that the eGFR calculated with the CKD-EPI equation was an independent predictor of the occurrence of MACE within 1 year after AMI. However, eGFR calculated with the MDRD Study equation did not have predictive value. Furthermore, the eGFR calculated with the CKD-EPI equation had incremental prognostic value for established risk factors (chi-square=5.78, p=0.016). Conclusion: The eGFR calculated using the CKD-EPI equation was an independent predictor of 1-year MACE in elderly patients with AMI.
INTRODUCTION
Coronary artery disease including acute myocardial infarction (AMI) is the leading cause of death worldwide 1) . Many factors are known to have substantial effects on the outcome of AMI. Renal failure is a powerful predictive factor for the outcome of AMI, even with mildly decreased renal function 2, 3) . In patients with end-stage renal disease, as defined by a glomerular filtration rate (GFR) of <10.0 mL/(min/1.73 m 2 ), the 2-year mortality rate after myocardial infarction (MI) is approximately 50%, which is twofold higher than that in the general population 4) . Therefore, precise assessment of kidney function is an important step in predicting the outcome of AMI.
GFR is the best index for evaluation of kidney function, but cannot be measured easily in clinical settings; hence, estimated GFR (eGFR) is calculated using equations. The Modification of Diet in Renal Disease (MDRD) Study equation has gained widespread acceptance 5, 6) . However, the MDRD equation has limited accuracy; therefore, a new equation for use in eGFR was developed: the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation. The CKD-EPI equation is more accurate than the MDRD Study equation, especially for estimating higher GFRs with less bias 7) . The eGFR calculated with the MDRD Study equation proved to be a predictive indicator for major risk factors of cardiovascular complications after AMI 2) . However, whether 
MATERIALS AND METHODS
The Kyungpook National University Hospital Acute Myocardial Infarction Registry (KNUH AMIR) is a Korean, retrospective, observational, single-center registry of AMI cases. All patients with ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) were included in the study. AMI was diagnosed based on characteristic presentation, serial electrocardiographic changes suggestive of infarction, and increased cardiac enzyme levels 8) .
Study Design
From November 2005 to February 2010, 1,372 patients with a final diagnosis of STEMI or NSTEMI were enrolled in the KNUH AMIR. This study was approved by the Institutional Review Board of the Kyungpook National University Hospital (2016-12-019). All NSTEMI or STEMI patients who visited Kyungpook National Hospital during the study period were included. Patients with missing data were excluded. We examined baseline patient demographic characteristics, initial presentation, initial vital signs, laboratory test results, echocardiographic findings, and medications used, including beta blockers, angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, and statins.
Study Variables
Baseline patient clinical characteristics, including age, sex, and cardiovascular risk factors (hypertension, diabetes mellitus, dyslipidemia, and smoking status), were identified. Initial vital sign parameters included systolic blood pressure, diastolic blood pressure, and heart rate. The Killip classification of AMI was determined by cardiologists. Laboratory tests, including blood samples, were performed on admission, except for the lipid profile, which was measured after at least 8 hours of fasting. Left ventricular ejection fraction (LVEF) was measured with 2-dimensional echocardiography and the Simpson method during hospitalization.
Assessing Renal Function
We assessed eGFR by using the MDRD Study and CKD-EPI formulas based on the initial creatinine examination. The MDRD Study equation is as follows: estimated GFR=175× 6) . At an estimated GFR of ≥60 mL/(min/1.73 m 2 ), the MDRD study equation has higher bias and lower precision than at an estimated GFR of <60 mL/(min/1.73 m 2 ). Racial bias also exists, as estimated GFR is less studied in Asian individuals 9) . .
Study Outcomes
We analyzed 1-year major adverse cardiac events (MACEs), defined as cardiac death, MI, and revascularization. Cardiac death was defined as death due to pump failure, arrhythmia, ventricular septal rupture, and free-wall rupture. MI was diagnosed by characteristic clinical presentation, serial changes on an electrocardiogram suggesting infarction, and an increase in cardiac enzymes. Revascularization included repeat percutaneous coronary intervention and coronary bypass graft for any reason. Follow-up data were obtained by reviewing medical records and telephone interviews with patients.
Statistical Analysis
As baseline characteristics, categorical variables were expressed as number with percentage, and differences between groups were analyzed by using the chi-square test. Continuous variables were expressed as mean±standard deviation and evaluated by using the independent t-test. To determine the factors predictive of 1-year cumulative MACE, multivariate Cox regression analyses were performed by using variables that were clinically significant (p<0.05). Hazard ratios (HRs) and 95% confidence intervals (CIs) were determined. All analyses were 2-tailed, with clinical significance defined as p<0.05. MedCalc ver. 12.5.0 (MedCalc, Ostend, Belgium) was used in receiver-operating characteristic (ROC) curve 
Outcomes
In Kaplan-Meier survival curve analysis, decreasing eGFRs were associated with increasing incidence rates of 1-year MACEs using both equations. The MDRD Study and CKD-EPI equations determined MACE incidence rates of 10.0% and 9.9% for G1, 10.2% and 9.0% for G2, 22.6% and 29.6% for G3, and 45.4% and 44.9% for G4/G5 (p<0.001 and p<0.001, respectively; Fig. 1 ). There were statistically significant differ- Figs. 1-3) .
In ROC curve analysis for prediction of 1-year MACE, the area under the curve (AUC) for the CKD-EPI equation was greater than that using the MDRD Study equation (AUC for the CKD-EPI and MDRD Study equations: 0.691 and 0.674, respectively [p=0.030]) (Fig. 2) 
11)
. In multivariate Cox proportional hazards analysis for 1-year MACEs, we used 2 models with independent predictors and eGFRs calculated with the MDRD Study and CKD-EPI equations. The eGFR based on the CKD-EPI equation could predict 1-year prognosis in patients with AMI (HR, 0.991; 95% CI, 0.983-0.998; p=0.015), whereas the MDRD Study equation could not (HR, 0.997; 95% CI, 0.991-1.002; p=0.257) ( Table 2) .
By using the likelihood ratio test and adding the GFR calculated with the CKD-EPI equation to the established risk factors, an incremental predictive value was obtained for 1-year MACEs (p=0.016). However, the GFR calculated with the MDRD equation yielded a significant increment (Fig. 3) .
DISCUSSION
Many studies have shown that CKD is an independent cardiovascular risk factor. These include the Studies of Left Ventricular Dysfunction (SOLVD), Survival and Ventricular Enlargement (SAVE), and Valsartan in Acute Myocardial Infarction (VALIANT) trials 2, 12, 13) . The presence of renal dysfunction after MI has also been proven to increase the incidence rate of adverse outcomes [14] [15] [16] . The mechanism by which renal impairment increases cardiovascular risk is not clear. Some studies suggest an association between atherosclerosis and endothelial dysfunction caused by oxidative stress, anemia, disturbed homeostasis of calcium phosphate, and inflammation [17] [18] [19] . Proteinuria, homocysteinemia, and uric acid are other risk factors that increase with renal decline 20, 21) . Serum creatinine level was used for evaluating renal function. Considering that serum creatinine level is affected by age, sex, race, and lean body mass, it has limited value as a marker of renal function. Therefore, GFR has been generally used 22, 23) . As GFR is difficult to assess, estimated GFR calculated by using equations has been widely used. In the SOLVD, SAVE, and VALIANT trials, the MDRD Study equation was used to estimate GFR ). In our study, the KaplanMeier survival curve showed the largest difference between the MDRD Study and CKD-EPI equations at CKD G3 (22.6% vs. 29.6%, respectively). This is possibly because many patients had a false-positive diagnosis of CKD G3.
This study had several clinical implications. First, it demonstrated that the eGFR calculated by using the CKD-EPI equation is not only a better index of kidney function but also has predictive value for long-term MACEs. In fact, the MDRD Study and Cockcroft-Gault formulas are more frequently used to calculate eGFR. Moreover, according to the current guidelines, the eGFR calculated with the MDRD Study equation is recommended for evaluation of kidney function in patients with acute coronary syndrome, as it takes race and sex into account 24) . Assessment of the predictive value of eGFR calculated with the CKD-EPI formula for long-term MACEs is therefore crucial. Second, our study adds novel insight to a previous study that showed statistical significance for the predictive value of eGFR, as calculated with the CKD-EPI equation, but in a different manner. Third, to the best of our knowledge, this is the first study to demonstrate that eGFR calculated with the CKD-EPI formula could be a predictive indicator for the Korean population.
Our study has some limitations. First, the lack of data about percutaneous coronary intervention (PCI) and periprocedural complications was the greatest limitation of this study. Since MACE is affected by coronary angiographic characteristics, including features of treated vessels, length of lesion, and type of stent, further investigation is necessary, with use of precise data for PCI and non-PCI groups.
Second, the data were collected from a retrospective analysis in a single center. Although we used multivariate analysis to statistically control for selection bias, the possibility of residual confounding factors cannot be excluded completely. For example, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta blockers, and the presence of hypertension, diabetes mellitus, and decreased LVEF were significantly greater in the event group than in the event-free group at baseline. This suggests that there were many confounding variables, even though multivariate analysis was used. Moreover, there were missing data for 9 patients. We excluded these from the analysis.
Fourth, only a maximum of 1 year of accumulated follow-up data were available for analysis, but evaluation of long-term prognosis is important. A follow-up study could provide useful data. Third, precise follow-up data on renal function were not available. Renal decline on follow-up could be an independent and important determinant of outcome 25) .
In conclusion, decreased eGFR was closely related to increased incidence rate of 1-year MACEs, regardless of whether the MDRD Study or the CKD-EPI equation was used. The eGFR calculated with the CKD-EPI equation could be a predictive indicator, with incremental value, for the occurrence of 1-year MACEs as a prognostic factor in AMI.
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